This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Open AccessSystematic Review
Blood Biomarkers as Optimization Tools for Computed Tomography in Mild Traumatic Brain Injury Management in Emergency Departments: A Systematic Review
by
Ángela Caballero Ballesteros
Ángela Caballero Ballesteros 1,*
,
María Isabel Alonso Gallardo
María Isabel Alonso Gallardo 2 and
Juan Mora-Delgado
Juan Mora-Delgado 3
1
Department of Medicine, University of Cádiz, INiBICA, 11003 Cádiz, Spain
2
Emergency Department, Hospital Universitario Nuestra Señora de Valme, Ctra. de Cádiz Km. 548,9, 41014 Sevilla, Spain
3
Internal Medicine and Palliative Care Clinical Management Unit, Hospital Universitario de Jerez de La Frontera, Ronda de Circunvalación S/N, 11407 Jerez de La Frontera, Spain
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2025, 15(8), 350; https://doi.org/10.3390/jpm15080350 (registering DOI)
Submission received: 2 June 2025
/
Revised: 3 July 2025
/
Accepted: 1 August 2025
/
Published: 3 August 2025
Abstract
Background/Objectives: Traumatic brain injury (TBI), especially mild TBI (mTBI), is frequently caused by traffic accidents, falls, or sports injuries. Although computed tomography (CT) is the gold standard for diagnosis, overuse can lead to unnecessary radiation exposure, increased healthcare costs, and emergency department saturation. Blood-based biomarkers have emerged as potential tools to optimize CT scan use. This systematic review aims to evaluate recent evidence on the role of specific blood biomarkers in guiding CT decisions in patients with mTBI. Methods: A systematic search was conducted in the PubMed, Cochrane, and CINAHL databases for studies published between 2020 and 2024. Inclusion criteria focused on adult patients with mTBI evaluated using both CT imaging and at least one of the following biomarkers: glial fibrillary acidic protein (GFAP), ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), and S100 calcium-binding protein B (S100B). After screening, six studies were included in the final review. Results: All included studies reported high sensitivity and negative predictive value for the selected biomarkers in detecting clinically relevant intracranial lesions. GFAP and UCH-L1, particularly in combination, consistently identified low-risk patients who could potentially forgo CT scans. While S100B also showed high sensitivity, discrepancies in cutoff values across studies highlighted the need for harmonization. Conclusions: Blood biomarkers such as GFAP, UCH-L1, and S100B demonstrate strong potential to reduce unnecessary CT imaging in mTBI by identifying patients at low risk of significant brain injury. Future research should focus on standardizing biomarker thresholds and validating protocols to support their integration into clinical practice guidelines.
Share and Cite
MDPI and ACS Style
Caballero Ballesteros, Á.; Alonso Gallardo, M.I.; Mora-Delgado, J.
Blood Biomarkers as Optimization Tools for Computed Tomography in Mild Traumatic Brain Injury Management in Emergency Departments: A Systematic Review. J. Pers. Med. 2025, 15, 350.
https://doi.org/10.3390/jpm15080350
AMA Style
Caballero Ballesteros Á, Alonso Gallardo MI, Mora-Delgado J.
Blood Biomarkers as Optimization Tools for Computed Tomography in Mild Traumatic Brain Injury Management in Emergency Departments: A Systematic Review. Journal of Personalized Medicine. 2025; 15(8):350.
https://doi.org/10.3390/jpm15080350
Chicago/Turabian Style
Caballero Ballesteros, Ángela, María Isabel Alonso Gallardo, and Juan Mora-Delgado.
2025. "Blood Biomarkers as Optimization Tools for Computed Tomography in Mild Traumatic Brain Injury Management in Emergency Departments: A Systematic Review" Journal of Personalized Medicine 15, no. 8: 350.
https://doi.org/10.3390/jpm15080350
APA Style
Caballero Ballesteros, Á., Alonso Gallardo, M. I., & Mora-Delgado, J.
(2025). Blood Biomarkers as Optimization Tools for Computed Tomography in Mild Traumatic Brain Injury Management in Emergency Departments: A Systematic Review. Journal of Personalized Medicine, 15(8), 350.
https://doi.org/10.3390/jpm15080350
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details
here.
Article Metrics
Article Access Statistics
For more information on the journal statistics, click
here.
Multiple requests from the same IP address are counted as one view.